About 2 Trademarks found for “XENH*”

Pharmaceutical and medicines for human purposes, namely: preparations for the prevention and treatment of oncological diseases; pharmaceutical preparations for the treatment of cardiovascular disease; pharmaceutical preparations for the purpose of increasing the effectiveness of other pharmaceutical products in the treatment of oncological diseases; pharmaceutical preparations for the treatment and prevention of cancer; pharmaceutical preparations for the treatment of diabetes; pharmaceutical preparations for the prevention of osteoporosis; pharmaceutical reparations for the central nervous system; pharmaceutical preparations for the treatment of gastro-intestinal diseases; pharmaceutical preparations for immunomodulation; pharmaceutical preparations for immune-enhancing; pharmaceutical preparations for intestinal health and for the prevention and treatment of respiratory diseases; pharmaceutical preparations for the treatment of digestive diseases; pharmaceutical preparations for the treatment of musculoskeletal disorders; pharmaceutical medicines for the treatment of gastrointestinal diseases; medicines for the treatment of mental health disorders; preparations for the treatment of eye diseases and conditions; medicines for the treatment of cardiovascular and cerebrovascular diseases; pharmaceutical preparations for the treatment of gastroenterological, intestine, bowel, stomach and digestive disorders; medicines for the treatment of gastrointestinal diseases; pharmaceutical antibody preparations for the treatment of cancer; pharmaceutical preparations for human use, namely, pharmaceutical antibodies for the treatment of cancer, respiratory diseases, auto-immune diseases, and for the prevention and treatment of solid organ transplant rejection; pharmaceutical preparations, namely, antibodies for the treatment of acute respiratory distress syndrome (ARDS); pharmaceutical preparations for the treatment of auto-immune diseases; anti-cancer preparations; pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations and substances for the prevention of cancer

Inhalable contrast agents for in-vivo imaging, in particular, inhalable hyperpolarized 129 Xenon (Xe) gas, delivered to a patient to obtain ventilation and gas exchange image and oscillation data of the patient's lungs; Contrast media for use with imaging medical equipment; Imaging agents for magnetic resonance imaging (MRI)

Software for recording, processing, transmitting, displaying, and/or analyzing data and images for use in connection with hyperpolarized gas production and delivery systems for medical imaging, namely, systems for providing hyperpolarized 129 Xenon (Xe) gas used to obtain magnetic resonance imaging (MRI) data of a patient's lungs